The House committee has advanced a new bill aiming to close a loophole in the Orphan Drug Act and increase market competition for prescription drugs. The Orphan Drug Act was passed in 1983 to [...]
In recent years, industry has been looking for ways to modernize the traditional clinical trial model. As such, companies are now being encouraged to try methodologies and strategies that will streamline processes and introduce [...]
WEP Clinical (WEP) announced today that it has entered into a partnership with BTG Specialty Pharmaceuticals (BTG), a division of Boston Scientific. Under the terms of the partnership, WEP will manage the exclusive distribution [...]